Takuto Miyagishima

Kushiro, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Risk-stratified evaluation of prophylactic strategies for delayed bleeding after gastric ESD: a multicenter retrospective study on clipping efficacy in the low-risk category.

Risk-stratified evaluation of prophylactic strategies for delayed bleeding after gastric ESD: a multicenter retrospective study on clipping efficacy in the low-risk category.

Journal: Acta gastro-enterologica Belgica

Published: July 08, 2026

Efgartigimod as a Steroid-sparing Therapy for Evans Syndrome: A Case Report.

Efgartigimod as a Steroid-sparing Therapy for Evans Syndrome: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: June 10, 2026

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Journal: Leukemia research

Published: May 04, 2026

Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients.

Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients.

Journal: International journal of hematology

Published: April 01, 2026

Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study.

Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study.

Journal: International journal of hematology

Published: February 24, 2026

Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.

Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 10, 2026

FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML.

FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML.

Journal: Annals of hematology

Published: July 19, 2024

Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia.

Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia.

Journal: Annals of hematology

Published: May 06, 2023

Effects of activation of an alcohol metabolic gene, cigarette smoking, and alcohol intake on the incidence of metachronous gastric cancer in patients who underwent endoscopic resection for gastric cancer: A multicenter retrospective pilot study.

Effects of activation of an alcohol metabolic gene, cigarette smoking, and alcohol intake on the incidence of metachronous gastric cancer in patients who underwent endoscopic resection for gastric cancer: A multicenter retrospective pilot study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: February 05, 2023

Infection with male and female Trichuris trichiura diagnosed in a non-endemic area.

Infection with male and female Trichuris trichiura diagnosed in a non-endemic area.

Journal: Clinical case reports

Published: December 05, 2022

Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study.

Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study.

Journal: International journal of hematology

Published: November 24, 2022

Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia.

Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia.

Journal: Annals of hematology

Published: October 11, 2022

Showing 1-12 of 61

Last Updated: 09/26/2026